These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 21941090)

  • 1. Recent developments for Pseudomonas vaccines.
    Sharma A; Krause A; Worgall S
    Hum Vaccin; 2011 Oct; 7(10):999-1011. PubMed ID: 21941090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine development for patients with cystic fibrosis.
    Döring G
    Expert Rev Vaccines; 2012 Mar; 11(3):259-61. PubMed ID: 22380816
    [No Abstract]   [Full Text] [Related]  

  • 3. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
    Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
    Front Immunol; 2019; 10():2497. PubMed ID: 31708925
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination against respiratory Pseudomonas aeruginosa infection.
    Grimwood K; Kyd JM; Owen SJ; Massa HM; Cripps AW
    Hum Vaccin Immunother; 2015; 11(1):14-20. PubMed ID: 25483510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress Toward the Elusive
    Merakou C; Schaefers MM; Priebe GP
    Surg Infect (Larchmt); 2018; 19(8):757-768. PubMed ID: 30388058
    [No Abstract]   [Full Text] [Related]  

  • 6. Genome-Based Approach Delivers Vaccine Candidates Against
    Bianconi I; Alcalá-Franco B; Scarselli M; Dalsass M; Buccato S; Colaprico A; Marchi S; Masignani V; Bragonzi A
    Front Immunol; 2018; 9():3021. PubMed ID: 30687303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal vaccination with a multivalent, live-attenuated vaccine induces multifactorial immunity against Pseudomonas aeruginosa acute lung infection.
    Kamei A; Coutinho-Sledge YS; Goldberg JB; Priebe GP; Pier GB
    Infect Immun; 2011 Mar; 79(3):1289-99. PubMed ID: 21149583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.
    Moore R; Kyd JM; Carzino R; Armstrong D; Grimwood K; Otczyk DC; Cripps AW
    Hum Vaccin Immunother; 2013 Mar; 9(3):506-14. PubMed ID: 23249482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice.
    Campodónico VL; Llosa NJ; Bentancor LV; Maira-Litran T; Pier GB
    Infect Immun; 2011 Aug; 79(8):3455-64. PubMed ID: 21628521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update.
    Vincent JL
    Future Microbiol; 2014; 9(4):457-63. PubMed ID: 24810345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
    Meynet E; Laurin D; Lenormand JL; Camara B; Toussaint B; Le Gouëllec A
    Vaccine; 2018 Mar; 36(14):1893-1900. PubMed ID: 29506924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.
    Johansen HK; Gøtzsche PC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001399. PubMed ID: 26298311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines for Pseudomonas aeruginosa: a long and winding road.
    Priebe GP; Goldberg JB
    Expert Rev Vaccines; 2014 Apr; 13(4):507-19. PubMed ID: 24575895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of Genomic Library and High-Throughput Screening of Pseudomonas aeruginosa Novel Antigens for Potential Vaccines.
    Xu W; Li L; Wen X; Liu Q; Liu Y; Wang X; Lei L; Chen Q; Liu L
    Biol Pharm Bull; 2020 Oct; 43(10):1469-1475. PubMed ID: 32779581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa.
    Zhang M; Sun C; Gu J; Yan X; Wang B; Cui Z; Sun X; Tong C; Feng X; Lei L; Han W
    Microbiol Immunol; 2015 Sep; 59(9):533-44. PubMed ID: 26249788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines and immunotherapy against Pseudomonas aeruginosa.
    Döring G; Pier GB
    Vaccine; 2008 Feb; 26(8):1011-24. PubMed ID: 18242792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding
    Sainz-Mejías M; Jurado-Martín I; McClean S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33291484
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.
    Johansen HK; Gøtzsche PC
    Cochrane Database Syst Rev; 2008 Oct; (4):CD001399. PubMed ID: 18843616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.
    Johansen HK; Gøtzsche PC
    Cochrane Database Syst Rev; 2013 Jun; (6):CD001399. PubMed ID: 23771707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.